Log In
Print this Print this

AD ER hydrocodone (S-718632)

  Manage Alerts
Collapse Summary General Information
Company Egalet Corp.
DescriptionAbuse-deterent, extended-release oral formulation of hydrocodone
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationPain
Indication DetailsTreat chronic pain
Regulatory Designation
PartnerShionogi & Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today